Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B
Clinical and Molecular Hepatology
; : 82-86, 2013.
Article
de En
| WPRIM
| ID: wpr-176452
Bibliothèque responsable:
WPRO
ABSTRACT
Telbivudine is an L-nucleoside analogue with potent antiviral activity against hepatitis B virus (HBV). Clinical trials have shown that telbivudine has a more potent and sustained antiviral activity with a lower frequency of viral resistance than lamivudine. Although there are several reports concerning the safety profile of telbivudine, most adverse events are described as mild and transient in nature. Here we report two cases of telbivudine-induced myopathy in patients with chronic hepatitis B who were siblings.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Antiviraux
/
Thymidine
/
Muscles squelettiques
/
Hépatite B chronique
/
Creatine kinase
/
Fratrie
/
Électromyographie
/
Maladies musculaires
Limites du sujet:
Adult
/
Humans
/
Male
langue:
En
Texte intégral:
Clinical and Molecular Hepatology
Année:
2013
Type:
Article